The new coronavirus strain emerging in China is making headlines across the world, with the disease sending entire cities into lockdown in a bid to control its spread.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
